Visit other SMART + STRONG sites:
AIDSMEDSREAL HEALTHTU SALUD
Subscribe to:
POZ magazine
E-newsletters
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » October 2008

Web Exclusives

Pomp, Circumstance and a Second Chance

The Low Down on the Down Low

Negotiating a Fair Price for the Norvir Tablet

» More

Most Talked About

(Un)deniable Evidence: A college professor takes on AIDS naysayers in his latest book (33)

Mom Imprisoned for Posting HIV Patient’s Medical Info Online (28)

New California Budget Slashes $55.5 Million From AIDS Funds (24)

CVS Criticized for Condom Lockup in Communities of Color (21)

Negotiating a Fair Price for the Norvir Tablet (12)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

10 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

October 10, 2008

Single Dose of Diflucan Good for Thrush

A single 750 milligram dose of Diflucan (fluconazole) is as safe and effective as taking 150 mg of Diflucan once daily for 14 days in curing oral candidiasis, also known as thrush, according to a study in the October 7 issue of Clinical Infectious Diseases.

Oral candidiasis is a common infection in people living with HIV, particularly those with low CD4 counts. A single-dose therapy potentially increases convenience and lowers the cost of treatment. Several previous studies have found that a single dose of Diflucan at 150 mg was at least partially effective in curing oral candidiasis without relapse. These studies, however, were small and found higher relapse rates compared with standard 14-day dosing.

To determine the efficacy of higher dose Diflucan taken only once, Omar Hamza, MD, of the Muhimbili University of Health and Allied Sciences in Dar Es Salaam, Tanzania, and his colleagues enrolled 220 HIV-positive patients with oral candidiasis. Half received a single dose of 750 mg Diflucan and the other half received 150 mg Diflucan, taken once daily for 14 days.

The clinical cure rates of the two strategies, determined by the resolution of symptoms, were nearly identical at roughly 95 percent. Lab tests taken from scrapings of the tongue revealed that 84 percent of the single-dose treatment group had total clearance of the candida fungus, while 75 percent of the 14-day treatment group had clearance of the fungus. The rate of side effects, which typically involved mild stomach upset, was very low in both groups. The authors, therefore, conclude that single-dose 750 mg Diflucan treatment may be safely used in HIV-positive people diagnosed with oral candidiasis. These results do not, however, apply to vaginal candidiasis or candidiasis that is more widespread throughout the body.

Search: Diflucan, fluconazole, oral candidiasis, thrush, Omar Hamza, Muhimbili University


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]

Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Watch Videos
Read the Blogs
Visit the Forums
Women's Hub
African American Hub
Latino Hub
Community Hub
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    Heartland4now
    Urbana
    Illinois


    timmerino
    Austin
    Texas


    ChicoDelBronx
    Bronx
    New York


    RobertLBC
    Long Beach
    California
Click here to join POZ Personals!
Talk to Us
Poll
Question: Do you believe that treatment as prevention places too much responsibility for the general public's health on people living with HIV?
Yes
No

Survey
How is your overall health?

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy